Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

MedWellAI (MWAI) Shares Outstanding (Weighted Average) (2016 - 2026)

MedWellAI has reported Shares Outstanding (Weighted Average) over the past 12 years, most recently at $6.2 million for Q4 2025.

  • Quarterly Shares Outstanding (Weighted Average) rose 554262.67% to $6.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.2 million through Dec 2025, up 554262.67% year-over-year, with the annual reading at $6.2 million for FY2025, 40.19% up from the prior year.
  • Shares Outstanding (Weighted Average) was $6.2 million for Q4 2025 at MedWellAI, up from $500000.0 in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $205.0 million in Q4 2021 and troughed at $1125.0 in Q4 2024.
  • The 5-year median for Shares Outstanding (Weighted Average) is $4.0 million (2023), against an average of $38.0 million.
  • Year-over-year, Shares Outstanding (Weighted Average) tumbled 99.97% in 2024 and then surged 554262.67% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $205.0 million in 2021, then tumbled by 99.02% to $2.0 million in 2022, then soared by 88.38% to $3.8 million in 2023, then tumbled by 99.97% to $1125.0 in 2024, then surged by 554262.67% to $6.2 million in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Shares Outstanding (Weighted Average) are $6.2 million (Q4 2025), $500000.0 (Q3 2025), and $6.2 million (Q2 2025).